Full text is available at the source.
Abstract
Mazdutide may impact body weight, HbA1c levels, and metabolic outcomes in adults with overweight or obesity and/or type 2 diabetes.
- Body weight reduction is associated with the administration of mazdutide.
- Changes in HbA1c levels may occur in response to mazdutide treatment.
- Mazdutide may influence various metabolic outcomes in the target population.
- Adverse events related to mazdutide treatment will be assessed.
Simplified